Literature DB >> 15369387

Comparing the conformational behavior of a series of diastereomeric cyclic urea HIV-1 inhibitors using the low mode:monte carlo conformational search method.

Carol A Parish1, Matthew Yarger, Kent Sinclair, Myrianne Dure, Alla Goldberg.   

Abstract

The conformational flexibility of a series of diastereomeric cyclic urea HIV-1 protease inhibitors has been examined using the Low Mode:Monte Carlo conformational search method. Force fields were validated by a comparison of the energetic ordering of the minimum energy structures on the AMBER/GBSA(water), OPLSAA/GBSA(water) and HF/6-311G/SCRF(water) surfaces. The energetic ordering of the minima on the OPLSAA /GBSA(water) surface was in better agreement with the quantum calculations than the ordering on the AMBER/GBSA(water) surface. An ensemble of low energy structures was generated using OPLSAA/GBSA(water) and used to compare the molecular shape and flexibility of each diastereomer to the experimentally determined binding affinities and crystal structures of closely related systems. The results indicate that diastereomeric solution-phase energetic stability, conformational rigidity and ability to adopt a chair conformation correlate strongly with experimental binding affinities. Rigid body docking suggests that all of the diastereomers adopt solution-phase conformations suitable for alignment with the HIV-1 protease; however, these results indicate that the binding affinities are dependent upon subtle differences in the P1/P1' and P2/P2' substituent orientations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369387     DOI: 10.1021/jm049716l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7.

Authors:  Jocelia P C Oliveira; Renato F Freitas; Leandro Silva de Melo; Thalita G Barros; Jorge A N Santos; Maria A Juliano; Sérgio Pinheiro; Michael Blaber; Luiz Juliano; Estela M F Muri; Luciano Puzer
Journal:  ACS Med Chem Lett       Date:  2013-12-06       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.